Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
Loren K. Mell(University of California San Diego), Arno J. Mundt(University of California San Diego), Casey W. Williamson(University of California, San Diego), Chonlakiet Khorprasert(Kaiser Permanente San Diego Medical Center), Steve Jiang(The University of Texas Southwestern Medical Center), Mei Shi(Xijing Hospital), Stephen F. Kry(The University of Texas MD Anderson Cancer Center), Linda Kašaová(University Hospital Hradec Králové), Catheryn M. Yashar(University of California San Diego), Terry A. Harrison(King Chulalongkorn Memorial Hospital), Igor Sirák(Charles University), R. Tarnawski(The Maria Sklodowska-Curie National Research Institute of Oncology), Walter Bosch(Washington University in St. Louis), John Einck(University of California, San Diego), Julie K. Schwarz(Washington University in St. Louis), Ronghui Xu(University of California, San Diego), Nan Li(University of California, San Diego), Lichun Wei(Xijing Hospital), William L. Straube(Washington University in St. Louis), Ruben Carmona(University of California, San Diego), Jeff M. Michalski(The University of Texas MD Anderson Cancer Center), Mary E. Wright(University of California, San Diego), Jessica Lowenstein(University of California, San Diego), Paul P. Koonings(King Chulalongkorn Memorial Hospital), Cheryl Saenz(University of California, San Diego), Michael McHale(University of California, San Diego), Gordon Honerkamp‐Smith(University of California, San Diego), Steve Plaxe(University of California, San Diego), Umesh Mahantshetty(Homi Bhabha National Institute)
International Journal of Radiation Oncology*Biology*Physics
November 23, 2016
Cited by 168
Related Papers
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632